These results suggest that PIC-BE is an effective anti-cancer compo und, and K562/ADM cell line with MDR has no resistance to it.

• 以上结果提示，PIC-BE是一种有效的抗肿瘤化合物，且已产生MDR的K562/ADM细胞对它不具耐药性。